The food and drug ministry of South Korea has said that the country has approved US pharmaceutical company Pfizer Inc's (NYSE:PFE) COVID-19 vaccine for use with children aged five to 11 years, Reuters news agency reported on Wednesday.
In a statement, the ministry said that children should get one-third of the regular dose, twice with a three week interval.
Children with significantly declined immunity can get a booster four weeks later, the statement added.
Bavarian Nordic files for chikungunya vaccine approval in Europe
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada
Philippine lawmakers call for probe into secret US propaganda operation
Gavi seeking funding to immunise poorest children
Sanofi partners with Biovac to manufacture polio vaccines in Africa
Scancell Holdings announces evaluation agreement with major biotechnology company
CSL Seqirus to provide pre-pandemic vaccines to EU
YS Biopharma's YS-HBV-002 receives Philippine clinical trial approval
Anixa Biosciences adds Dr Sanjay Juneja to Cancer Business Advisory Board
Circio ends TG01 cancer vaccine licence deal with IOVaxis in China